Perovskite solar cells (PSCs) could conquer the mass market within a few years, perhaps even being produced in Europe. Their ...

As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...

Full-body defense does not always look the way textbooks say it should. In planarian flatworms, a newly identified cell type ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Nature is beautiful, powerful and essential. But nature is not always gentle. The same biological world that gives rise to ...

Cece Calhoun ’21, medical director of Yale’s Sickle Cell Program, reflects on the challenges of building teams and structures ...

Nanoparticles are widely used in medicine to deliver drugs, genes or imaging agents to specific parts of the body. Once a ...

I recommend a speculative buy on Factorial Energy Inc. (FAC) due to attractive risk/reward at near-SPAC valuation despite ...

Perovskite solar cells (PSCs) are considered strong candidates for mass‑market adoption within the next few years, with the ...

The new headquarters will expand workforce capacity and showcase innovative approaches to workplace well-being and energy ...

Spacebar alignment breaks when columns, fonts, or layouts change, but Excel's custom number formatting keeps everything ...

A New Orleans man became the first person in Louisiana to be functionally cured of sickle cell disease. More people need ...